000 01342 a2200349 4500
005 20250517114756.0
264 0 _c20170228
008 201702s 0 0 eng d
022 _a1535-5675
024 7 _a10.2967/jnmt.116.177873
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBasu, Sandip
245 0 0 _a177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors.
_h[electronic resource]
260 _bJournal of nuclear medicine technology
_cDec 2016
300 _a248-250 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms, Connective Tissue
_xdiagnostic imaging
650 0 4 _aOctreotide
_xanalogs & derivatives
650 0 4 _aOrganometallic Compounds
650 0 4 _aOsteomalacia
650 0 4 _aParaneoplastic Syndromes
650 0 4 _aPositron Emission Tomography Computed Tomography
650 0 4 _aReceptors, Somatostatin
_xmetabolism
650 0 4 _aRecurrence
650 0 4 _aSkull
700 1 _aFargose, Preeti
773 0 _tJournal of nuclear medicine technology
_gvol. 44
_gno. 4
_gp. 248-250
856 4 0 _uhttps://doi.org/10.2967/jnmt.116.177873
_zAvailable from publisher's website
999 _c26424702
_d26424702